Lecturer on Public Health Institute Biomedical Science Abel Salazar. Porto University (Portugal)
|
|
- Branden Marshall
- 6 years ago
- Views:
Transcription
1 Curriculum vitae PERSONAL INFORMATION Raquel Duarte WORK EXPERIENCE Lecturer on Public Health Institute Biomedical Science Abel Salazar. Porto University (Portugal) 2001 Present Pulmonologist Hospital Centre of Vila Nova de Gaia/Espinho (Portugal) Senior Graduate Assistant since Medical Director Adjunct Hospital Centre of Vila Nova de Gaia (Portugal) Tuberculosis Consultant Consultancy on National strategies in order to control tuberculosis in the country Advisor for the Tuberculosis Program of the Northern Regional Health Administration North Health Administration (Portugal) Assistant Department of Clinical Epidemiology, Predictive Medicine and Public Health University of Porto Medical School (Portugal) Member of TBNET TBNET (Germany) Member of TBNET since Was Secretary of the TBNET from 2011 to Mission of Support to the Guinea Bissau Tuberculosis Program Portuguese North Health Administration (Portugal) Included a national team, as tuberculosis expert, giving technical advice Present Coordinator of the Multi-resistant Tuberculosis Reference Center of the North Region of Portugal North Health Administration (Portugal) Is responsible for the clinical management of all M/XDRTB cases in the North region and their contacts Member of the Direction of the Portuguese Board of Pneumology Portuguese Medical Association (Portugal) 4/1/18 European Union, Page 1 / 5
2 Professor Department of Clinical Epidemiology, Predictive Medicine and Public Health University of Porto Medical School (Portugal) Assistant coordinator of the National TB Program Tuberculosis program is, since 2012, connected with HIV/AIDS Program with one Director responsible for the 2 programs. She is responsible for the tuberculosis program. Evaluates, identify the needs and strategies needed to decrease TB in the country. Identifies the training needs among health professionals, develops training material and deliver it - as written guidance and as personal training. Makes connections and develops protocols with NGO and other institutions outside the Health Minister - such as prisons. Disease Group National Focal Point European Centre for Disease Prevention and Control (ECDC) (Sweden) 2013 Present Coordinator of the National Reference Center for M/XDR Tuberculosis Evaluates and monitors all cases of M/XDRTB in the country; identify and implement strategies in order to detect MDRTB cases earlier, assure that all cases identified start treatment, monitors the regimen treatment prescribed (all MDRTB cases are managed in clinical reference centres for MDRTB with highly trained professionals) Member of the Assembly 10 Long Range Planning Committee of European Respiratory Society The Long Range Planning Committee (LPRC) is a consulting body, with the objective of providing strategic development and to assist the Assembly Heads Secretary General of The Union Europe Region International Union Against Tuberculosis and Lung Disease. Europe Region Officers (France) Provides technical assistance and consultancy to the President and Vice President. Member of the task force from European Respiratory Society to work with the Thorax Latino-American Society on the road-map on tuberculosis elimination on Latin America Works as consultant, advising on the strategies to be implemented. Expert of the ERS/WHO TB Consilium Gives expert consultancy on difficult cases of tuberculosis, particularly M/XDRTB Member of the TB Disease Network Coordination Committee European Centre for Disease Prevention and Control (Sweden) Coordinator of the Infectious Disease Unit. Epidemiology Research Unit (EPIUnit) 4/1/18 European Union, Page 2 / 5
3 Institute of Public Health of the University of Porto (Portugal) Research group in the domain of infectious diseases. Director of the Thorax and Circulation Management Unit Centro Hospitalar de Vila Nova de Gaia. Portugal (Portugal) Responsible for the management of the Unit that comprises 4 different departments: Cardiology, Cardio-Thoracic Surgery, Pneumology and Vascular Surgery 2015 Present Expert on the Ad hoc Working Group on TB Advocacy The Ad hoc Working Group on TB Advocacy was established in September Its main task is the refocusing of ERS Tuberculosis (TB) advocacy projects drawing in different areas of the society dealing with this topic. Works as an expert in the group Present Member of the ECDC Ad hoc scientific panel European Centre for Disease Prevention and Control (Sweden) Has given consultancy and technical advise on tuberculosis, latent tuberculosis infection, actions regarding vulnerable populations. Some documents have derived from this consultancy, the last one being the Guidance on tuberculosis control in vulnerable and hard-to-reach populations Present Vice Chair International Union Against Tuberculosis and Lung Disease.Europe Region Officers (France) 2017 Present Chair of the Tuberculosis Group. Assembly 10: Respiratory Infection EDUCATION AND TRAINING 1991 Medical Degree Institute Biomedical Science Abel Salazar. Porto University (Portugal) 1993 General internship Centro Hospitalar do Porto (Portugal) 1999 Residency on Pulmonary Medicine Centro Hospitalar de Vila Nova de Gaia (Portugal) 1999 Master degree on Public Health University of Porto Medical School (Portugal) 2011 PhD on Public Health University of Porto Medical School (Portugal) 2017 Master in Management and Health Care Economics Faculty of Economics, University of Porto (Portugal) 4/1/18 European Union, Page 3 / 5
4 ADDITIONAL INFORMATION Expertise Publications A selection of 10 publications in the last year are presented below: 1. Dedicoat MJ, Günther G, Crudu V, Duarte R, Gualano G, Magis-Escurra C, Rumetshofer R, Skrahina A, Spinu V, Tiberi S, Viiklepp P, van Leth F, Lange C; for TBNET. Tuberculosis treatment outcomes in Europe: based on treatment completion, not cure. Am J Respir Crit Care Med Nov 1;196(9): Mendes-Bastos P, Macedo R, Duarte R. Treatment of hidradenitis suppurative with rifampicin: have we forgotten tuberculosis? Br J Dermatol Oct;177(4):e150-e Sousa M, Gomes M, Gaio AR, Duarte R. Nosocomial tuberculosis prevention in Portuguese hospitals: a cross sectional evaluation. Int J Tuberc Lung Dis Aug 1;21(8): Apolinário D, Ribeiro AI, Krainski E, Sousa P, Abranches M, Duarte R. Tuberculosis inequalities and socio-economic deprecation in Portugal. Int J Tuberc Lung Dis Jul 1;21(7): Magis-Escurra C, Günther G, Lange C, Alexandru S, Altet N, Avsar K, Bang D, Barbuta R, Bothamley G, Ciobanu A, Crudu V, Davilovits M, Dedicoat M, Duarte R, Gualano G, Kunst H, de Lange W, Leimane V, McLaughlin AM, Muylle I, Polcová V, Popa C, Rumetshofer R, Skrahina A, Solodovnikova V, Spinu V, Tiberi S, Viiklepp P, van Leth F; for TBnet. Treatment outcomes of MDR-TB and HIV co-infection in Europe. Eur Respir J Jun 8;49(6). pii: Solovic I, Abubakar I, Sotgiu G, Dara M, Goletti D, Duarte R, Aliberti S, de Benedictis FM, Ward B, Teixeira V, Gratziou C, Migliori GB. Standard operating procedures for tuberculosis care. Eur Respir J Jun 1;49(6). pii: Borisov SE, Dheda K, Enwerem M, Romero Leyet R, D'Ambrosio L, Centis R, Sotgiu G, Tiberi S, Alffenaar JW, Maryandyshev A, Belilovski E, Ganatra S, Skrahina A, Akkerman O, Aleksa A, Amale R, Artsukevich J, Bruchfeld J, Caminero JA, Carpena Martinez I, Codecasa L, Dalcolmo M, Denholm J, Douglas P, Duarte R, Esmail A, Fadul M, Filippov A, Davies Forsman L, Gaga M, Garcia-Fuertes JA, García-García JM, Gualano G, Jonsson J, Kunst H, Lau JS, Lazaro Mastrapa B, Teran Troya JL, Manga S, Manika K, González Montaner P, Mullerpattan J, Oelofse S, Ortelli M, Palmero DJ, Palmieri F, Papalia A, Papavasileiou A, Payen MC, Pontali E, Robalo Cordeiro C, Saderi L, Sadutshang TD, Sanukevich T, Solodovnikova V, Spanevello A, Topgyal S, Toscanini F, Tramontana AR, Udwadia ZF, Viggiani P, White V, Zumla A, Migliori GB. Effectiveness and safety of bed aquiline containing regimens in the treatment of MDR and XDR-TB: a multicentre study. Eur Respir J May 21;49(5). pii: Nunes C, Duarte R, Veiga AM, Taylor B. Who are the patients that default tuberculosis treatment? space matters! Epidemiol Infect Apr;145(6): Dias M, Gaio R, Sousa P, Abranches M, Gomes M, Oliveira O, Correia-Neves M, Ferreira E, Duarte R. Tuberculosis among the homeless: should we change the strategy? Int J Tuberc Lung Dis Mar 1;21(3): Francisco J, Oliveira O, Felgueiras Ó, Gaio AR, Duarte R. How much is too much alcohol in 4/1/18 European Union, Page 4 / 5
5 tuberculosis? Eur Respir J Jan 18;49(1). Projects Memberships Other Relevant Information 4/1/18 European Union, Page 5 / 5
Beyond multidrug-resistant tuberculosis in Europe: a TBNET study
INT J TUBERC LUNG DIS 19(12):1524 1527 Q 2015 The Union http://dx.doi.org/10.5588/ijtld.15.0274 Beyond multidrug-resistant tuberculosis in Europe: a TBNET study G. Günther,* F. van Leth, N. Altet, M. Dedicoat,
More informationFactors influencing tuberculosis screening in healthcare workers in Portugal
Factors influencing tuberculosis screening in healthcare workers in Portugal To the Editor: Although the incidence of tuberculosis (TB) has increased in healthcare workers (HCWs) [1 3], several studies
More informationFaster for less: the new shorter regimen for multidrug-resistant tuberculosis
6 American Thoracic Society, CDC, Infectious Diseases Society of America. Treatment of tuberculosis. MMWR Recomm Rep 2003; 52: 1 77. 7 de Kantor IN, Ambroggi M, Poggi S, et al. Human Mycobacterium bovis
More informationChildhood Vaccination and Immunisation
DIRECTORATE GENERAL FOR INTERNAL POLICIES POLICY DEPARTMENT A: ECONOMIC AND SCIENTIFIC POLICY WORKSHOP Childhood Vaccination and Immunisation Brussels, 19 June 2013 MEETING DOCUMENT Policy Department A:
More informationTuberculosis, social determinants and co-morbidities (including HIV)
Pulmonol. 2018;24(2):115-119 www.journalpulmonology.org REVIEW Tuberculosis, social determinants and co-morbidities (including HIV) R. Duarte a,b,c,, K. Lönnroth d,e, C. Carvalho f, F. Lima a, A.C.C. Carvalho
More informationProgrammatic latent tuberculosis control in the European Union and candidate countries - Draft conclusions
ECDC GUIDANCE Programmatic latent tuberculosis control in the European Union and candidate countries - Draft conclusions Gerard de Vries Dominik Zenner On behalf of the ad hoc scientific panel appointed
More informationERJ Express. Published on April 20, 2018 as doi: /
ERJ Express. Published on April 20, 2018 as doi: 10.1183/13993003.02678-2017 Early View Task force report ERS/ECDC Statement: European Union Standards for Tuberculosis Care - 2017 update GB Migliori, G
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Günther G, Lange C, Alexandru S, et al. Treatment outcomes
More informationComparison of effectiveness and safety of imipenem/clavulanate- versus meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TB
ORIGINAL ARTICLE TUBERCULOSIS Comparison of effectiveness and safety of imipenem/clavulanate- versus meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TB Simon Tiberi 1,30, Giovanni
More informationTB and MDR/XDR-TB in European Union and European Economic Area countries: managed or mismanaged?
Eur Respir J 2012; 39: 619 625 DOI: 10.1183/09031936.00170411 CopyrightßERS 2012 TB and MDR/XDR-TB in European Union and European Economic Area countries: managed or mismanaged? G.B. Migliori*, ***, G.
More informationFuture directions for the ERS: Presidential plans
EDITORIAL ERS PRESIDENTIAL PLAN Future directions for the ERS: Presidential plans Francesco Blasi 1, Peter J. Barnes 2, Mina Gaga 3 and Giovanni Battista Migliori 4 Affiliations: 1 Dipartimento Fisiopatologia
More informationUniversity of Groningen
University of Groningen Bedaquiline and Delamanid Combination Treatment of 5 Patients with Pulmonary Extensively Drug-Resistant Tuberculosis Maryandyshev, Andrey; Pontali, Emanuele; Tiberi, Simon; Akkerman,
More informationA review of Outcomes of Treatment among 29 cases of Extensively Drug Resistant Tuberculosis in Johannesburg
A review of Outcomes of Treatment among 29 cases of Extensively Drug Resistant Tuberculosis in Johannesburg Ntambwe Malangu 1 and Mame Dieynaba DIA-DIOP 2 Abstract The purpose of this study was to describe
More informationEffectiveness and safety of meropenem/ clavulanate-containing regimens in the treatment of MDR- and XDR-TB
ERJ Express. Published on March 10, 2016 as doi: 10.1183/13993003.02146-2015 ORIGINAL ARTICLE IN PRESS CORRECTED PROOF Effectiveness and safety of meropenem/ clavulanate-containing regimens in the treatment
More informationPeople not Pathogens. Al Story
People not Pathogens Al Story Plan Changing epidemiology ACF - Case management - Missed opportunities Epi transition Exposure and infection Overcrowding Homelessness Incarceration Health care access Progression
More informationDelamanid and bedaquiline to treat multidrug-resistant and extensively drug-resistant tuberculosis in children: a systematic review
Review Article Delamanid and bedaquiline to treat multidrug-resistant and extensively drug-resistant tuberculosis in children: a systematic review Lia D Ambrosio 1,2, Rosella Centis 1, Simon Tiberi 3,
More informationPyrazinamide resistance in MDR and extensively drug-resistant tuberculosis.
Biomedical Research 2017; 28 (8): 3532-3536 ISSN 0970-938X www.biomedres.info Pyrazinamide resistance in MDR and extensively drug-resistant tuberculosis. Lan Yao, Qing Zhang, Yidan Liu, Heping Xiao * Tuberculosis
More informationCompassionate use of bedaquiline in highly drug-resistant tuberculosis patients in Mumbai, India
AGORA RESEARCH LETTER Compassionate use of bedaquiline in highly drug-resistant tuberculosis patients in Mumbai, India To the Editor: Bedaquiline, a mycobacterial ATP synthase inhibitor [1], is the first
More informationCURRICULUM VITAE (SUMMARY)
CURRICULUM VITAE (SUMMARY) Full Name: Lino Manuel Martins Gonçalves Birthdate: September 23, 1960 Loulé (Portugal) Civil State: Married Nationality: Portuguese Current Address: Rua Carlos Oliveira, 17,
More informationThe European Union standards for tuberculosis care: do they need an update?
EDITORIAL EU STANDARDS FOR TB CARE The European Union standards for tuberculosis care: do they need an update? Marieke J. van der Werf 1, Andreas Sandgren 1, Lia D Ambrosio 2, Francesco Blasi 3 and Giovanni
More informationHIV and Tuberculosis in Eastern Europe
HIV and Tuberculosis in Eastern Europe Daria N. Podlekareva Meeting Standard of Care for HIV and Coinfections in Europe Rome, November 25-16 2014 TB notification rates (per 100.000) European region 2012
More informationMODULE SIX. Global TB Institutions and Policy Framework. Treatment Action Group TB/HIV Advocacy Toolkit
MODULE SIX Global TB Institutions and Policy Framework Treatment Action Group TB/HIV Advocacy Toolkit 1 Topics to be Covered Global TB policy and coordinating structures The Stop TB Strategy TB/HIV collaborative
More informationTB/HIV in the WHO European Region Overview, Priorities & Response
TB/HIV in the WHO European Region Overview, Priorities & Response 16 th Core Group Meeting TB/HIV Working Group Stop TB Partnership Almaty, Kazakhstan May 2010 Martin Donoghoe Andrei Dadu, Smiljka de Lussigny
More informationTuberculosis. Edited by Christoph Lange and Giovanni Battista Migliori. Pulmonary Hypertension
Pulmonary Hypertension NUMBER 58 / DECEMBER 2012 EUROPEAN RESPIRATORY monograph Pulmonary hypertension plays an increasingly important role in contemporary medicine. It may present as discrete disease
More informationCURRICULUM VITAE. Date of birth July 30th, 1960 PERSONAL INFORMATIONS. Curriculum vitae of Alberto Matteelli pag. 1/6
E U R O PA S S CURRICULUM VITAE PERSONAL INFORMATIONS Surname/First name Alberto Matteelli Address Passirano (Brescia) Piazza Europa 24, ZIP 25050 Telephone (s) +39.030.3995802 (office) Mobile: +30.339.3344033
More informationExperience with Pyrazinamide and Rifampin Regimens for Latent TB Infection
Experience with Pyrazinamide and Rifampin Regimens for Latent TB Infection Krista Powell, MD, MPH Co-Project Officer, National Surveillance for Severe Adverse Events Associated with LTBI Treatment Lead,
More informationRiga Dr Al Story
Riga 2013 Dr Al Story Plan TB control - Flawed assumptions 21 st century challenges People not Pathogens Intensified case finding - next steps Protect the public Treat the patient Infection & Inequality
More informationMid study Advisory Group Meeting, 14 th February 2011
Work Package 3 ( WP3 ): Tuberculosis related service needs, and accessibility and quality of HIV/TB integrated service provision, among injecting drug users Mid study Advisory Group Meeting, 14 th February
More informationERS/ECDC Statement: European Union standards for tuberculosis care, 2017 update
ERS OFFICIAL DOCUMENTS ERS/ECDC STATEMENT ERS/ECDC Statement: European Union standards for tuberculosis care, 2017 update Giovanni Battista Migliori 1,26, Giovanni Sotgiu 2,26, Senia Rosales-Klintz 3,26,
More informationNew Frontiers: Innovation and Access
8 th Regional TB Symposium - Tashkent, Uzbekistan New Frontiers: Innovation and Access New Guidelines: An Opportunity for National Programmes and Patients: Evidence for new WHO recommendations on MDR-TB
More informationTB 2015 burden, challenges, response. Dr Mario RAVIGLIONE Director
TB 2015 burden, challenges, response Dr Mario RAVIGLIONE Director Addis Ababa, Ethiopia 11-13 November 2015 Overview TB basics TB burden & challenges Response: End TB Strategy DAY 1 What is TB? Definition
More informationWhat really happens to tuberculosis patients classified as lost to follow-up in West Yorkshire?
Research articles What really happens to tuberculosis patients classified as lost to follow-up in West Yorkshire? M Day (matthew.day2@nhs.net) 1,2, A Middlemiss 1, J Thorpe 1, E Okereke 1 1. Health Protection
More informationDrug-resistant tuberculosis in Naples,
Ann Ist Super Sanità 2016 Vol. 52, No. 4: 603-607 DOI: 10.4415/ANN_16_04_23 Drug-resistant tuberculosis in Naples, 2008-2013 Annalisa Del Giudice 1, Alessandro Mustazzolu 2, Angelo Iacobino 2, Rossella
More informationProposal for a standardised treatment regimen to manage pre- and extensively drug-resistant tuberculosis cases
EDITORIAL TUBERCULOSIS Proposal for a standardised treatment regimen to manage pre- and extensively drug-resistant tuberculosis cases Jose A. Caminero 1,2, Alberto Piubello 2,3, Anna Scardigli 4 and 5
More informationTurning Off the Spigot Reducing Nosocomial Drug Resistant TB. Edward A. Nardell, MD Harvard Medical School/PIH Brigham & Women s Hospital
Turning Off the Spigot Reducing Nosocomial Drug Resistant Transmission Edward A. Nardell, MD Harvard Medical School/PIH Brigham & Women s Hospital is an airborne infection Every case of MDR/XDR prevented
More informationGUIDELINES, STATEMENTS & STANDARDS ON TUBERCULOSIS [AS OF FEBRUARY 2005] PART I. GROUPED BY AGENCY/ORGANIZATION
GUIDELINES, STATEMENTS & STANDARDS ON TUBERCULOSIS [AS OF FEBRUARY 2005] PART I. GROUPED BY AGENCY/ORGANIZATION Agency/Organization Name of the Guide/Statement Available at World Health Organization 1
More informationControlling TB in the era of HIV
Controlling TB in the era of HIV Christy Hanson, PhD, MPH TB Research Advisor Amy Bloom, MD TB/HIV Advisor TB Incidence rates highest in Africa Estimated new TB cases (all forms) per 100 000 population
More informationGUIDELINES, STATEMENTS & STANDARDS ON TUBERCULOSIS [AS OF NOVEMBER 2004] PART I. GROUPED BY AGENCY/ORGANIZATION
GUIDELINES, STATEMENTS & STANDARDS ON TUBERCULOSIS [AS OF NOVEMBER 2004] PART I. GROUPED BY AGENCY/ORGANIZATION Agency/Organization Name of the Guide/Statement Available at World Health Organization 1
More informationProgress Report March 2016
Progress Report March 2016 Table of Contents Background to project 3 Assays performed to date 3 Correctional Services 5 Peri-Mining 6 Rif Concordance 7 Training: Laboratory and Clinical 7 Challenges identified
More informationAvian influenza in poultry, wild and captive birds (AI)
Avian influenza in poultry, wild and captive birds (AI) Analysis of ADNS data since 01/2018 Reporting period: 2018-01-01 2018-10-28 Data query: 2018-10-30 AGES DSR Austrian Agency for Health and Food Safety
More informationUntreatable tuberculosis: is surgery the answer?
EDITORIAL TUBERCULOSIS Untreatable tuberculosis: is surgery the answer? Masoud Dara 1, Giovanni Sotgiu 2, Richard Zaleskis 1 and Giovanni Battista Migliori 3 Affiliations: 1 WHO Regional Office for Europe,
More informationChildhood TB and new TB drugs in the WHO European Region
Andrei Dadu Carl Cordonnier Maxim Dondiuk Childhood TB and new TB drugs in the WHO European Region Kigali, Rwanda, 09/10/ 2017 Dr Martin van den Boom, MD, MSc PH, WHO Regional Office for Europe, Joint
More informationFact sheets on sustainable development goals: health targets. Tuberculosis
SDG target 3.3: by 2030, end the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases and combat hepatitis, waterborne diseases and other communicable diseases. Fact sheets on sustainable
More informationPrimer on Tuberculosis (TB) in the United States
Primer on Tuberculosis (TB) in the United States The purpose of this primer is to provide instructors who have no prior background in TB research or clinical care with basic knowledge that they may find
More informationEfficacy, safety and tolerability of linezolid for the treatment of XDR-TB: a study in China
ORIGINAL ARTICLE TUBERCULOSIS Efficacy, safety and tolerability of linezolid for the treatment of XDR-TB: a study in China Shenjie Tang 1,2,8, Lan Yao 2,8, Xiaohui Hao 2,8, Xia Zhang 3, Gang Liu 4, Xin
More informationMonthly measles and rubella monitoring report
SURVEILLANCE REPORT Monthly measles and rubella monitoring report December 2018 Period covered: 1 November 2017 to 31 October 2018 Introduction This monitoring report is based on measles and rubella data
More informationPlan. A bit about TB What I do What I should do
B R E A K F A S T Plan A bit about TB What I do What I should do 575,475 583,350 810,120 667,228 755,605 7,753,555 1,068,532 2,199,500 3,442,675 1,698,957 3,255,944 2,724,347 745,514 121 39 58 113 3,440
More informationCURRICULUM VITAE ANWAR SHAFI, MD
CURRICULUM VITAE ANWAR SHAFI, MD Work Address Postal address Southern Illinois University School of Medicine P.O. Box l9658 Springfield, IL 62794-9658 E-Mail Address Present Position ashafi@siumed.edu
More information2010 global TB trends, goals How DOTS happens at country level - an exercise New strategies to address impediments Local challenges
Outline of what it will take Tuberculosis Elimination 25: Global and Local Challenges Anne Fanning, MD November 9, 211 21 global TB trends, goals How DOTS happens at country level - an exercise New strategies
More informationWhat can be done against XDR-TB?
What can be done against XDR-TB? Dr Matteo Zignol Stop TB Dep. World Health Organization Geneva 16 th Swiss Symposium on tuberculosis Münchenwiler, 22 March 2007 XDR-TB Extensive Drug Resistance XDR =
More informationTHE PORTUGUESE COMMUNITY SCREENING NETWORK
THE PORTUGUESE COMMUNITY SCREENING NETWORK COBATEST Annual Network Meeting 14 May 2018 Presented by: Name goes here Paula Meireles, on behalf of the Community Screening Network EPIUnit ISPUP FUNDING (from
More informationDelamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis
Eur Respir J 2013; 41: 1393 1400 DOI: 10.1183/09031936.00125812 CopyrightßERS 2013 ERJ Open articles are open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence
More informationThe WHO END-TB Strategy
ENDING TB and MDR-TB The WHO END-TB Strategy Dr Mario RAVIGLIONE Director Joint GDI/GLI Partners Forum WHO Geneva, 27 April 2015 This talk will deal with TB Burden Progress, Challenges Way Forward Who
More informationElections to EACVI Board
Elections to EACVI Board 2018-2020 Application for the position: EACVI Secretary 1. Your Identity Title Family Name(s) First Name(s) Birth Date Institute/Organisation Department City Country Prof. Di Salvo
More informationNew and repurposed drugs to treat multidrug- and extensively drug-resistant tuberculosis
J Bras Pneumol. 2018;44(2):153-160 http://dx.doi.org/10.1590/s1806-37562017000000436 REVIEW ARTICLE 1. Faculdade de Medicina, Universidade Federal do Rio Grande do Sul UFRGS Porto Alegre (RS) Brasil. 2.
More informationInstitution Qualification obtained Year Basic Degree(s): National University of Singapore MBBS 1999
CV (1) Personal Particulars Full Name: Dr Ang Seng Bin, MBBS, MMed (FM), FCFP Age: 43 (2) Current Appointment Details Institution of primary appointment: KK Women s and Children s Secondary Appointment(s),
More informationTuberculosis Now! Jon S Friedland MA, FRCPE, FMedSci. Infectious Diseases & Immunity
Tuberculosis Now! Jon S Friedland MA, FRCPE, FMedSci Infectious Diseases & Immunity What is TB Now? Epidemiology including international migration Biomarkers New treatments TB notification rate per 1
More informationCosts of tuberculosis disease in the EU a systematic analysis and cost calculation. Germany. Member of the German Center for Lung Research (DZL)
ERJ Express. Published on August 15, 2013 as doi: 10.1183/09031936.00079413 Costs of tuberculosis disease in the EU a systematic analysis and cost calculation Diel R 1, Vandeputte J 2, de Vries G 3, Stillo
More informationXin Zhang 1,2, Matthew E. Falagas 3, Konstantinos Z. Vardakas 3, Rui Wang 4, Rong Qin 4, Jin Wang 3, Youning Liu 1. Introduction
Original Article Systematic review and meta-analysis of the efficacy and safety of therapy with linezolid containing regimens in the treatment of multidrug-resistant and extensively drug-resistant tuberculosis
More informationCURRICULUM VITAE PERSONAL DATA WORK EXPERIENCE AWARDS POST-DOCTORAL TRAINING
CURRICULUM VITAE PERSONAL DATA Name: GIL FILIPE RAMADA FARIA Birthdate: May 18th, 1979 Birthplace: Porto, Portugal Marital status: Married Address: Rua das Flores, 225-4440-073 CAMPO VLG - Portugal Telephone:
More informationRole of the UN agencies in the Prevention and control of NCDs Dr Jacob Kumaresan Executive Director WHO office at the United Nations
Role of the UN agencies in the Prevention and control of NCDs Dr Jacob Kumaresan Executive Director WHO office at the United Nations 27 February 2013, SEA Regional Consultation on NCDs New perspectives
More informationMultidrug-resistant Tuberculosis - World, Europe, Switzerland
Multidrug-resistant Tuberculosis - World, Europe, Switzerland Magglingen March 23, 2017 peter.helbling@bag.admin.ch Topics Definitions Epidemiology of TB and MDR-TB worldwide Treatment outcome results
More informationDept of Internal Medicine, Central Hospital, Kristianstad (Sweden) Dept of Internal Medicine, Central Hospital, Kristianstad (Sweden)
Curriculum vitae PERSONAL INFORMATION Charles Cline WORK EXPERIENCE June 1984 January 1985 Dept of Internal Medicine, Central Hospital, Kristianstad (Sweden) February 1985 January 1987 Internship Central
More informationTuberculosis Procedure ICPr016. Table of Contents
Tuberculosis Procedure ICPr016 Table of Contents Tuberculosis Procedure ICPr016... 1 What is Tuberculosis?... 2 Any required definitions/explanations... 2 NHFT... 2 Tuberculosis (TB)... 3 Latent TB...
More informationRole of Sugery in treatment of patient with MDR/XDR pulmonary TB - Experience from Georgia
Role of Sugery in treatment of patient with MDR/XDR pulmonary TB - Experience from Georgia Sergo Vashakidze, MD, PhD Coordinator of Surgical Works at the National Center for Tuberculosis and Lung Diseases,
More informationTB trends and TB genotyping
Management of a TB Contact Investigation for Public Health Workers Albuquerque, NM October 1, 214 TB trends and TB genotyping Marcos Burgos MD October 1, 214 Marcos Burgos, MD has the following disclosures
More informationWR s Speech on inaugural ceremony of Community based Programmatic Management of Drug resistance TB (CPMDT).
WR s Speech on inaugural ceremony of Community based Programmatic Management of Drug resistance TB (CPMDT). The Chief guest Prof. Dr. A.F.M. Ruhul Haque M.P Hon ble Minister, Ministry of Health and Family
More informationOriginal Article A new LNR surgical staging system in non HIV-related cervical tuberculosis lymphadenitis
Int J Clin Exp Med 2017;10(8):12589-12594 www.ijcem.com /ISSN:1940-5901/IJCEM0047301 Original Article A new LNR surgical staging system in non HIV-related cervical tuberculosis lymphadenitis Zhi Wang 1,
More information- UPDATE - Implementation and roll-out of Xpert MTB/RIF October 2011
- UPDATE - Implementation and roll-out of Xpert MTB/RIF October 2011 This document provides an update on the global roll-out of Xpert MTB/RIF, the WHO-endorsed test for the rapid and simultaneous detection
More informationon July 24, 2018 by guest
AAC Accepts, published online ahead of print on 17 June 2013 Antimicrob. Agents Chemother. doi:10.1128/aac.00120-13 Copyright 2013, American Society for Microbiology. All Rights Reserved. 1 2 WHO Group
More informationGlobal Fund Approach to Health System Strengthening
Global Fund Approach to Health System Strengthening WHO Expert consultation on positive synergies between health systems and Global Health Initiatives Geneva, 29-30 May 2008 Dr Stefano Lazzari, Director
More informationSocial determinants of infectious diseases
Social determinants of infectious diseases Informal Health Council, 5-6 July 2011, Sopot, Poland President, Commissioner, Ministers, thank you for asking me to contribute to your debate. Over the next
More informationKashif Raza. Jul Jun Govt. Zamindar Degree College, FSc. Certificate Bio, Phys, Chem Gujrat, Pakistan GRADUATE:
Kashif Raza Education and Training UNDERGRADUATE: Jul. 1989 Jun. 1991 Govt. Zamindar Degree College, FSc. Certificate Bio, Phys, Chem Gujrat, Pakistan. 1991 GRADUATE: Sep.1991- Aug. 1997 Nishtar Medical
More informationDAILY PROGRAMME HIGHLIGHTS
DAILY PROGRAMME HIGHLIGHTS Please visit the programme page on the conference website for a full list of conference sessions and satellite meetings taking place at the CCIB or offsite, as well as a daily
More informationEconomic and Social Council
United Nations Economic and Social Council Distr.: General 13 September 2013 ECE/WG.1/2013/4 Original: English Economic Commission for Europe Working Group on Ageing Sixth meeting Geneva, 25-26 November
More informationEfficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis.
ERJ Express. Published on April 10, 2012 as doi: 10.1183/09031936.00022912 Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis.
More informationCommittee of Senior Representatives Tenth Meeting Oslo, Norway 11 December 2006
Committee of Senior Representatives Tenth Meeting Oslo, Norway 11 December 2006 Reference CSR 10/7.1/1 Title Proposed Terms of Reference for the EG on HIV/AIDS Submitted by Secretariat Summary / Note As
More informationNational Xpert MTB/RIF Programme
National Xpert MTB/RIF Programme 1. Background to Project This project was initiated at the request of the Honorable Minister of Health, Dr Aaron Motsoaledi, in early 2011, following the World Health Organization
More informationMultidrug- and extensively drug-resistant tuberculosis: a persistent problem in the European Union European Union and European Economic Area
Rapid communications Multidrug- and extensively drug-resistant tuberculosis: a persistent problem in the European Union European Union and European Economic Area C Ködmön (csaba.kodmon@ecdc.europa.eu)
More information95% of care homes show clear care improvements1. Elevating Awareness & Creating Discussions Key 2016 Advocacy and Industry Efforts
95% of care homes show clear care improvements1 Elevating Awareness & Creating Discussions Key 2016 Advocacy and Industry Efforts Innovations & Solutions aligned with Industry priorities Elevating awareness
More informationReceived: March Accepted after revision: April First published online: May
Correspondence: Mathieu S. Bolhuis, University of Groningen, University Medical Centre Groningen, Dept of Clinical Pharmacy and Pharmacology, University of Groningen, PO Box 30.001, 9700 RB Groningen,
More informationThe health of the South African mining workforce: trends, progress and challenges Jill Murray and Zodwa Ndlovu
The health of the South African mining workforce: trends, progress and challenges Jill Murray and Zodwa Ndlovu International Public Health Symposium, University of the Witwatersrand, School of Public Health,
More information* WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Care and
ERJ Express. Published on August 9, 2007 as doi: 10.1183/09031936.00077307 RAPID PUBLICATION Clinical and operational value of the XDR-TB definition Giovanni Battista Migliori *, Giorgio Besozzi, Enrico
More informationArterial Stiffness and Early Vascular Aging
International Post-Graduation Program Arterial Stiffness and Early Vascular Aging 4th Edition 18th - 19 th November, 2015. Center for the Research and Treatment of Arterial Hypertension and Cardiovascular
More informationFactors Associated with Multidrugresistant Tuberculosis: Comparison of Patients Born Inside and Outside of the Czech Republic
The Journal of International Medical Research 2010; 38: 1156 1163 [first published online as 38(3) 26] Factors Associated with Multidrugresistant Tuberculosis: Comparison of Patients Born Inside and Outside
More informationHCV Elimination Mini Policy Summit Eliminating HCV in Greece Hosted by MEP Georgios Kyrtsos European Parliament, 22 November 2017, A5E-3, 10:00 12:00
HCV Elimination Mini Policy Summit Eliminating HCV in Greece Hosted by MEP Georgios Kyrtsos European Parliament, 22 November 2017, A5E-3, 10:00 12:00 Speakers biographies In order of appearance Georgios
More informationTB facts & figures Microbiology of TB Transmission of TB Infection control in health care settings Special cases Resistant TB Masks
1 TB facts & figures Microbiology of TB Transmission of TB Infection control in health care settings Special cases Resistant TB Masks 2 Page 1 4 NHS Lothian Infection Prevention and Control Study Day On
More informationData Visualization - Basics
Data Visualization - Basics The Visualization Process ACQUIRE PARSE FILTER MINE REPRESENT REFINE INTERACT Sales Data (US $ in thousands) Region Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Domestic
More informationTB Outbreak in a Homeless Shelter
TB Outbreak in a Homeless Shelter Objectives Epidemiology of Outbreak Population Health Interventions Population Health Goals 2007 One active case identified Less than compliant Prolonged recovery Contact
More informationTuberculosis in Alameda County, 2009
Tuberculosis in Alameda County, 29 Alameda County Public Health Department Tuberculosis Overview Tuberculosis (TB) is a communicable disease caused by the bacteria Mycobacterium tuberculosis. TB is spread
More information1. POSITION TITLE : Technical Advisor, TB and HIV. 2. PERIOD OF PERFORMANCE : Two (2) years, with the possibility of
VACANCY POSITION GLOBAL FUND COORDINATING UNIT (GFCU) 1. POSITION TITLE : Technical Advisor, TB and HIV 2. PERIOD OF PERFORMANCE : Two (2) years, with the possibility of 3. PLACE OF PERFORMANCE : Maseru,
More informationInternational Standards for Tuberculosis Care Barbara J. Seaworth, MD August 22, 2007
TB Along the US/Mexico Border El Paso, Texas August 22-23, 2007 International Standards for Tuberculosis Care Barbara J. Seaworth, MD August 22, 2007 Barbara J Seaworth MD Medical Director Heartland National
More informationWhere are we with the NCD Movement?
Where are we with the NCD Movement? Cary Adams CEO, Union for International Cancer Control (UICC) Chair, NCD Alliance April 2013, Taipei Definitions We = our generation NCD Movement = advocacy at the highest
More informationThe Opioid Addiction Emergency In Virginia June 8, 2017
The Opioid Addiction Emergency In Virginia June 8, 2017 Marissa J. Levine, MD MPH State Health Commissioner Virginia Department of Health Chronic Disease of Addiction Definition: A primary, chronic disease
More informationT uberculosis control aims to reduce mortality and morbidity
302 EVIDENCE BASED PUBLIC HEALTH POLICY AND PRACTICE Tuberculosis treatment outcome monitoring in England, Wales and Northern Ireland for cases reported in 2001 Delphine Antoine, Clare E French, Jane Jones,
More informationCardiac safety of bedaquiline: a systematic and critical analysis of the evidence
EDITORIAL RESPIRATORY INFECTIONS AND TUBERCULOSIS Cardiac safety of bedaquiline: a systematic and critical analysis of the evidence Emanuele Pontali 1, Giovanni Sotgiu 2, Simon Tiberi 3,4, Lia D Ambrosio
More informationOverall aim Improving the access to and the quality of health and social services for marginalised people
Overall aim Improving the access to and the quality of health and social services for marginalised people To tackle health inequalities and to improve prevention, care and treatment services, targeting
More informationDavid W. Miller, M.D., L.Ac. February 2017
PERSONAL INFORMATION Name: David W. Miller, M.D., L.Ac. Citizenship: United States Home Address: 1614 W. Carmen Ave., Chicago, IL 60640 Home Phone: 773-960-8901 Business Address: East-West Integrated Medicine,
More informationERJ Express. Published on October 11, 2012 as doi: /
ERJ Express. Published on October 11, 2012 as doi: 10.1183/09031936.00136312 Drug resistance beyond XDR-TB: results from a large individual patient data meta-analysis G.B. Migliori 1 *, G. Sotgiu 2 *,
More information